Europe — EMA
Modafinil Orifarm
GNH USA supplies Modafinil Orifarm (Modafinil), a wakefulness‑promoting agent for narcolepsy, sleep‑apnea related daytime sleepiness and shift‑work sleep
Request sourcing
What is Modafinil?
Modafinil, the active ingredient in Modafinil Orifarm, is a wakefulness‑promoting agent presented as an oral tablet for oral use. It treats excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift‑work sleep disorder. GNH USA supplies Modafinil Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Modafinil used for?
Modafinil acts on the central nervous system to improve wakefulness in sleep‑related disorders.
Narcolepsy: reduces daytime sleepiness and improves alertness. Obstructive sleep apnea‑related excessive daytime sleepiness: enhances wakefulness despite residual sleep‑disordered breathing. Shift work sleep disorder: decreases sleepiness during scheduled work hours, supporting better performance.
What are the side effects of Modafinil?
Adverse reactions may occur with Modafinil use.
Common Side Effects: - Headache - Nausea - Insomnia - Anxiety
Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome - Psychiatric disturbances including depression, hallucinations, or mania - Cardiovascular events such as hypertension, arrhythmia, or myocardial infarction
What precautions apply to Modafinil?
Before prescribing Modafinil, clinicians should consider several safety aspects.
Assess cardiovascular status: evaluate blood pressure and heart disease before initiating. Monitor psychiatric history: avoid in patients with uncontrolled psychosis. Avoid use in severe hepatic impairment: adjust or contraindicate based on liver function. Inform about potential for dependence: use only as prescribed. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.
What does Modafinil interact with?
Modafinil can interact with several medicines, requiring careful management.
Major Interactions (Avoid): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce Modafinil exposure. - Co‑administration with other wakefulness‑promoting agents (e.g., armodafinil): risk of excessive stimulation. - Monoamine oxidase inhibitors: potential for hypertensive crisis.
Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease hormonal efficacy, requiring backup methods. - Antidepressants (SSRIs, SNRIs): may increase the incidence of side effects such as anxiety. - Antihypertensives: blood pressure changes may necessitate dose adjustment.
Frequently asked questions
What conditions is Modafinil Orifarm used to treat?+
How does Modafinil work to promote wakefulness?+
What is the usual dose of Modafinil Orifarm?+
Is Modafinil Orifarm safe to use during pregnancy or breastfeeding?+
How do I order Modafinil Orifarm from GNH USA?+
How does Modafinil compare with other wakefulness‑promoting drugs?+
What are the recommended storage conditions for Modafinil Orifarm?+
How is Modafinil Orifarm administered?+
What are the most serious risks associated with Modafinil Orifarm?+
Who should not use Modafinil Orifarm?+
Product details
Related products

Modafinil 100 mg/1
Modafinil · 100 mg

Modafinil 200 mg/1
Modafinil · 200 mg

Modafinil 100 mg/1
Modafinil · 100 mg

Modafinil 100 mg/1
Modafinil · 100 mg